| Income Statement |
| Operating Expenses | 71.87M |
|
| Research and Development Expense | 53.14M |
| Selling, General and Administrative Expense | 18.73M |
| Operating Income | -71.87M |
| Interest Expense | 1.98M |
| Income Tax Expense | -311.00K |
| Net Income | -70.93M |
| Net Income Common Stock | -70.93M |
| Net Income Common Stock (USD) | -70.93M |
| Consolidated Income | -70.93M |
| Earnings per Basic Share | -0.77 |
| Earnings per Basic Share (USD) | -0.77 |
| Earnings per Diluted Share | -0.77 |
| Earning Before Interest & Taxes (EBIT) | -69.26M |
| Earning Before Interest & Taxes (USD) | -69.26M |
| Weighted Average Shares | 92.19M |
| Weighted Average Shares Diluted | 92.19M |
| Balance Sheet |
| Cash and Equivalents | 124.66M |
| Cash and Equivalents (USD) | 124.66M |
| Investments | 146.19M |
| Investments Current | 146.19M |
| Trade and Non-Trade Receivables | 2.96M |
| Current Assets | 280.35M |
| Property, Plant & Equipment Net | 50.33M |
| Total Assets | 333.59M |
| Debt Current | 4.08M |
| Total Debt | 76.35M |
| Current Liabilities | 50.09M |
| Debt Non-Current | 72.27M |
| Total Liabilities | 123.05M |
| Accumulated Retained Earnings (Deficit) | -1.19B |
| Accumulated Other Comprehensive Income | 5.56M |
| Shareholders Equity | 210.54M |
| Shareholders Equity (USD) | 210.54M |
| Assets Non-Current | 53.24M |
| Total Debt (USD) | 76.35M |
| Liabilities Non-Current | 72.96M |
| Trade and Non-Trade Payables | 5.65M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.65M |
| Net Cash Flow from Financing | 10.45M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 20.65M |
| Capital Expenditure | -135.00K |
| Issuance (Purchase) of Equity Shares | 10.65M |
| Issuance (Repayment) of Debt Securities | -195.00K |
| Net Cash Flow from Investing | 75.12M |
| Net Cash Flow - Investment Acquisitions and Disposals | 75.26M |
| Net Cash Flow from Operations | -65.95M |
| Effect of Exchange Rate Changes on Cash | 1.04M |
| Share Based Compensation | 7.05M |